Original Research
Published on 03 Mar 2017
Toll-Like Receptor Ligand-Based Vaccine Adjuvants Require Intact MyD88 Signaling in Antigen-Presenting Cells for Germinal Center Formation and Antibody Production
in Vaccines and Molecular Therapeutics

- 7,687 views
- 24 citations














